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Abstract
Extracellular ATP enhances the mitogenic activity of ﬁbroblast growth factor-2 (FGF2) in astrocytes, but the molecular
mechanism underlying this synergistic interaction is not known. To determine whether the potentiating effect of
extracellular ATP involves cell cycle control mechanisms, we have measured the expression of cyclins that are induced in
different phases of the cell cycle in primary cultures of rat cortical astrocytes. We found that ATP potentiated the ability
of FGF2 to stimulate expression of cyclin D1, a regulator of cell cycle entry, as well as cyclin A, a regulator of DNA
replication. Because FGF2 and P2 purinergic receptors are coupled to extracellular signal regulated protein kinase (ERK),
a key member of a signaling cascade that regulates proliferation, we also investigated the role of ERK in regulating cyclin
expression induced by FGF2 and ATP. We found that the potentiating effect of ATP on cyclin expression was
signiﬁcantly reduced by U0126, an inhibitor of MEK, the upstream activator of ERK. P2 receptor agonist studies revealed
that UTP enhanced FGF2-induced cyclin expression and mitogenesis whereas 2-methylthioADP was ineffective. By
contrast, 20,30-O-(4-benzoyl)-benzoyl-ATP markedly inhibited FGF2-induced mitogenesis. Consistent with opposing
effects of P2Y and P2X receptors on mitogenesis, UTP stimulated a transient activation of ERK whereas BzATP
stimulated a more sustained ERK signal. These ﬁndings suggest that signaling by P2Y receptors, most likely of the
purine/pyrimidine subtype, enhance the ability of FGF2 to stimulate entry into a new cell cycle, as well as DNA
replication, by an ERK-dependent mechanism, whereas signaling by P2X receptors, possibly the P2X7 subtype, inhibits
FGF2-induced mitogenesis in astrocytes. Interactions between P2Y, P2X and polypeptide growth factor signaling
pathways may have important implications for CNS development as well as injury and repair.
Introduction
Although normally quiescent, astrocytes in the adult
nervous system have the ability to proliferate. In particular,
astrocyte proliferation in adult brains has been observed
after breakdown of the blood brain barrier such as occurs
after stab wounds and head trauma [1Y6]. In addition,
astrocytes can act as neural stem cells in the normal and
regenerating brain [7]. Studies of cell cycle regulatory pro-
teins in astrocytes have demonstrated that addition of
epidermal growth factor (EGF) to conﬂuent astrocytes
resulted in the formation of multiple cell layers and el-
evated levels of cyclin D1 [8] which is induced in response
to mitogenic signals. Cell cycle entry and progression is
regulated by the expression of proteins termed cyclins
[9]. Cyclin levels are low in quiescent cells but increase
in response to mitogenic growth factors during distinct
phases of the cell cycle. For example, cyclin D1 is in-
creased during entry and progression through G1 phase
while cyclin A is increased in S phase during which time
DNA is replicated. The expressed cyclins bind to and ac-
tivate enzymes termed cyclin-dependent protein kinases,
thereby leading to changes in phosphorylation of key pro-
teins that control various phases of the cell cycle. It was
suggested that changes in the expression of cell cycle
regulatory proteins may be involved in the increased
proliferation observed in the gliosis that occurs after injury
to the adult CNS [8].
Fibroblast growth factor-2 (FGF2) is increased after
CNS injury (e.g., [10]) and can stimulate the gliotic re-
sponse in cultured astrocytes (e.g., [11]) and in vivo [12].
When applied to mechanically wounded astrocytes, FGF2
enhanced proliferation, stellation and cell migration [13].
ATP is also released upon tissue injury and may contribute
to gliosis [14]. When ATP or other nucleotide receptor
agonists were added to astrocytes in culture, key hallmarks
of gliosis were observed, i.e., increases in proliferation,
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In vivo, GFAP and astrocyte proliferation were increased
after infusion of an ATP analog into rat brain [18]. These
effects of ATP were blocked by nucleotide receptor an-
tagonists, thereby indicating that P2 purinergic receptors
mediate the gliotic actions of ATP in vivo.
Extracellular ATP can enhance the mitogenic activity
of polypeptide growth factors in several cell types (re-
viewed in [19]). In astrocytes, we found that extracellular
ATP markedly potentiated FGF2-induced mitogenesis
[20]. However, little is known about the interactive effects
of extracellular nucleotides and growth factors on cell
cycle regulatory mechanisms, particularly in cells of the
central nervous system. Here we report for the ﬁrst time
that extracellular ATP and UTP enhance FGF2-induced
expression of cyclins involved in cell cycle entry and pro-
gression through the G1 and S phases of the cell cycle by a
mechanism involving extracellular signal regulated protein
kinase (ERK). We also demonstrate that BzATP inhibits the
ability of FGF2 to stimulate mitogenesis, thereby suggest-
ing that P2Y and P2X receptors exert opposing effects on
FGF2-induced proliferation in astrocytes.
Materials and methods
Cell culture and treatment
Primary cultures of astrocytes were obtained from neonatal
rat (Fischer) cerebral cortices as previously described [20];
the experimental procedure was approved and monitored
by the Animal Studies Subcommittee at the Miami VA
Medical Center and the Animal Care and Use Committee,
University of Miami School of Medicine. Cells were
seeded at densities of 1.5 and 4 million cells per 60 mm
and 100 mm dishes, respectively; cells were not replated
before use. At least 95% of the cell population was
astrocytes, as determined by staining with cell-speciﬁc
markers [20]. Experiments were conducted with 4Y5-week-
old cultures. Prior to treatment, cells which had been main-
tained in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
containing 10% horse serum were shifted to the quiescent
phase by incubation in serum-free DMEM for 48 h. Stock
solutions of ATP and other nucleotides (Sigma Chemical
Co., St. Louis, MO) and FGF2 (recombinant human FGF2;
R&D Systems, Minneapolis, MN) were divided into single-
use aliquots and stored at j80 -C.
Immunoblotting
Cyclin expression was measured by immunoblotting. After
treatment with FGF2 and/or nucleotides, cells were rinsed
twice in ice-cold PBS and lysed in a buffer containing
20 mM Tris, pH 7.0, 0.27 M sucrose, 1 mM EDTA, 1 mM
EGTA, 50 mM NaF, 1 mM dithiothreitol, 1 mM sodium
orthovanadate, 10 mM sodium b-glycerophosphate, 5 mM
sodium pyrophosphate, 1 mg/ml pepstatin A, 4 mM leu-
peptin, 0.3 U/ml aprotinin, 100 mg/ml 4-(2-aminoethyl)-
benzenesulfonylﬂuoride (AEBSF) and 1% NP-40. Protein
concentrations were determined by the Coomassie micro
method (Bio Rad Laboratories, Hercules, CA) with bovine
serum albumin as standard. Lysates containing equal
amounts of protein (50 mg )w e r es u b j e c t e dt oS D S -
polyacrylamide gel electrophoresis [21] using 11% (w/v)
acrylamide and transferred to nitrocellulose ﬁlters with a
Genie electrophoretic blotter (Idea Scientiﬁc Inc., Minne-
apolis, MN) for 1 h at 12 V in a transfer buffer containing
25 mM Tris, 192 mM glycine and 20% (v/v) methanol.
Membranes were incubated with a blocking solution
containing 20 mM Tris, pH 7.7, 137 mM NaCl, 0.1%
(v/v) Tween 20 (TTBS) and 5% (w/v) nonfat dry milk
for 1 h at room temperature, rinsed in TTBS, and then
incubated for 1 h at room temperature with speciﬁc anti-
bodies (anti-cyclin D1, 1/500 dilution; anti-cyclin A, 1/200
dilution; or b-actin, 1/50,000 dilution) in blocking solution
containing 0.02% sodium azide. Polyclonal antibodies re-
cognizing cyclin D1 (sc-718) and cyclin A (sc-596) were
purchased from Santa Cruz Biotechnology, Santa Cruz, CA,
and monoclonal antibodies recognizing b-actin were
obtained from Sigma Chemical Co., St. Louis, MO. Fol-
lowing three rinses in TTBS, membranes were incubated for
1 h at room temperature with peroxidase-conjugated donkey
anti-rabbit or anti-mouse IgG (Amersham Pharmacia Bio-
tech, Piscataway, NJ) diluted 1/5000 in blocking solution.
Membranes were washed three times in TTBS, and cyclin
D1, cyclin A and b-actin were detected by ECL (Super-
Signal West Femto Maximum Sensitivity Substrate; Pierce
Biotechnology, Rockford, IL) with Kodak Biomax ﬁlm
(Eastman Kodak Company, Rochester, NY). Films were
scanned and densitometrically analysed using Molecular
Analyst Software (Bio-Rad Laboratories, Hercules, CA). In
some cases, membranes were blocked and probed according
to the manufacturer’s instructions for analysis with an
Odyssey Infrared Imaging System (Li-Cor Biosciences,
Lincoln, NB) using Alexa Fluor 680-labeled anti-rabbit IgG
(Molecular Probes, Eugene, OR) or IRDye 800 labeled anti-
mouse IgG (Rockland Immunochemicals, Gilbertsville, PA)
secondary antibodies. For quantiﬁcation, cyclin/actin ratios
were measured to correct for minor loading differences. To
compare levels of cyclin expression among different experi-
ments, data were calculated as fold stimulation compared to
FGF2.
DNA synthesis
3H-Thymidine incorporation was measured as previously
described [20]. Data were expressed as cpm/mg protein.
Protein concentrations were determined by the modiﬁed
Lowry procedure with bovine serum albumin as standard
[22].
ERK1/2 phosphorylation
Quiescent cultures were treated at 37 -C with vehicle, UTP
or BzATP for the times indicated. Cells were lysed in SDS
sample buffer [21] and protein concentrations determined
by the modiﬁed Lowry procedure [22]. Cell lysates,
containing 35 mg of protein, were subjected to SDS-PAGE
330 J.T. Neary et al.(11% acrylamide gel) and Western Blot analysis was
performed using speciﬁc phospho-ERK monoclonal anti-
body (Thr202/Tyr204; 1/5000 dilution) from Cell Signal-
ing Technology, Beverly, MA, and total-ERK polyclonal
antibody (1/5000 dilution) from Santa Cruz Biotechnology,
Santa Cruz, CA. For visualization, membranes were
blocked and probed according to the manufacturer’s
instructions for analysis with an Odyssey Infrared Imaging
System (Li-Cor Biosciences, Lincoln, NB) using IR-Dye
800 conjugated anti-mouse IgG (1/5000 dilution) and IR-
Dye 700DX conjugated anti-rabbit IgG (1/10,000 dilution)
obtained from Rockland Immunochemicals, Gilbertsville,
PA. Intensities of phospho-ERK1/2 and total ERK1/2
bands were quantiﬁed and ratios of phospho-ERK1/2/total
ERK1/2 were calculated and compared to control (vehicle-
treated) cultures.
Statistical analyses
Data were analyzed by Student’s t-test for two groups or
repeated measures ANOVA for multiple groups followed
by post-hoc comparisons (Bonferroni test) using an Instat
software package (GraphPad Software, San Diego, CA,
USA). Replicate experiments were conducted with cultures
from different seedings.
Results
Expression of cyclin D1 and cyclin A
To determine whether interactive effects of extracellular
ATP and FGF2 involve cell cycle regulation, we measured
the expression of cyclins that are induced in different
phases of the cell cycle. Quiescent, primary cultures of rat
cortical astrocytes were treated with ATP (100 mM), FGF2
(25 ng/ml) or a combination of ATP and FGF2. Expression
of cyclin D1, a cell cycle regulatory protein induced in G1
phase in response to stimulation by growth factors, was
measured by immunoblotting and identiﬁed by co-migra-
tion with a positive control (Figure 1A). Blots were also
probed with anti-actin antibodies as a loading control.
Cyclin D1 expression was stimulated by FGF2 (Figure 1A).
At the level of detection, ATP alone was without effect.
However, when cells were treated with both ATP and
FGF2, the expression of cyclin D1 was potentiated. An
analysis of variance revealed an overall signiﬁcant dif-
ference among the groups and planned comparisons re-
vealed that the ATP + FGF2 group was signiﬁcantly
different (P G 0.05) from the FGF2 group (Figure 1B).
These results suggest that extracellular ATP can enhance
the ability of FGF2 to stimulate entry of astrocytes into the
cell cycle.
To determine whether extracellular ATP also enhances
the effect of FGF2 on entry and progression of astrocytes
through S phase, cyclin A expression was measured.
Quiescent, primary cultures of rat cortical astrocytes were
treated with ATP (100 mM), FGF2 (25 ng/ml) or a
combination of ATP and FGF2. Cyclin A expression was
measured by immunoblotting and identiﬁed by co-migra-
tion with a positive control (Figure 2A). Blots were probed
with anti-actin antibodies as a loading control. We found
that ATP also potentiated the ability of FGF2 to stimulate
expression of cyclin A (Figure 2A). An analysis of var-
iance from group data revealed an overall signiﬁcant dif-
ference and planned comparisons revealed that the ATP +
FGF2 group was signiﬁcantly different (P G 0.01) from the
FGF2 group (Figure 2B). These results indicate that
extracellular ATP also enhances the ability of FGF2 to
induce the expression of cyclin A, a protein involved in
entry and progression through the S phase, the DNA
replication stage of the cell cycle.
Enhancement of FGF2-induced cyclin expression by
extracellular ATP involves ERK signaling
To investigate the mechanism by which extracellular
ATP enhances cyclin expression induced by FGF2, we
focused on ERK, a key member of a signaling pathway
that regulates mitogenesis [23]. Both FGF2 and extracel-
lular ATP stimulated ERK in rat cortical astrocytes
[24Y26], and blockade of the ERK cascade inhibited
ATP-induced mitogenesis in astrocytes [27]. To determine
whether the potentiation of FGF2-induced cyclin D1
expression by extracellular ATP in primary cultures of
Figure 1. Extracellular ATP enhances cyclin D1 expression induced by
FGF2. A) Quiescent, primary cultures of rat cortical astrocytes were
treated with ATP (100 mM), FGF2 (25 ng/ml) or a combination of ATP
and FGF2 for 20 h. Lysates were subjected to SDS-PAGE, and cyclin D1
expression was measured by immunoblotting. Cyclin D1 was identiﬁed by
co-migration with a positive control (PC). Blots were also probed with
anti-actin antibodies as a loading control. ATP potentiated the ability of
FGF2 to stimulate expression of cyclin D1. B) Results (mean T SEM)
from three independent experiments in which astrocyte cultures were
treated as described in (A). FGF2-induced cyclin D1 expression was
signiﬁcantly enhanced by extracellular ATP (*P G 0.05).
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inhibitor of MEK, the upstream activator of ERK. U0126
(10 mM) was added to quiescent, primary cultures of rat
cortical astrocytes 30 min prior to treatment with ATP
(100 mM), FGF2 (25 ng/ml) or a combination of ATP
and FGF2. When the ERK cascade was blocked, the up-
regulation of cyclin D1 by FGF2 was signiﬁcantly
inhibited (P G 0.05) (Figures 3A and B). Importantly,
blockade of the ERK cascade also signiﬁcantly inhibited
the ability of extracellular ATP to enhance cyclin D1
expression induced by FGF2 (P G 0.001) (Figures 3A
and B).
Because blockade of the ERK cascade inhibited cyclin
D1 expression induced by FGF2 and extracellular ATP,
and because cyclin A is expressed subsequent to cyclin D1,
we reasoned that inhibition of the ERK cascade should also
reduce cyclin A expression. To test this, U0126 (10 mM)
was added to quiescent, primary cultures of rat cortical
astrocytes 30 min prior to treatment with ATP (100 mM),
FGF2 (25 ng/ml) or a combination of ATP and FGF2
(Figures 4A and B). We found that blockade of the ERK
cascade signiﬁcantly inhibited the expression of cyclin A
induced by FGF2 (P G 0.05) as well as the potentiation of
FGF2-induced cyclin A by extracellular ATP (P G 0.001).
These ﬁndings indicate that the ERK cascade plays an
important role in mediating the co-mitogenic activity of
extracellular ATP.
P2Y and P2X receptors exert opposing effects on FGF2-
induced mitogenesis
To investigate the type(s) of P2 purinergic receptors in-
volved in the synergistic effects of extracellular ATP on
cyclin expression induced by FGF2, we conducted studies
with UTP and 2methylthioADP (2MeSADP), agonists of
P2Y2/4 and P2Y1 receptors, respectively. Quiescent astro-
cyte cultures were treated with FGF2 (25 ng/ml), ATP
(100 mM), UTP (100 mM), 2MeSADP (10 mM) or a com-
bination of FGF2 and each nucleotide. We found that cy-
clin A expression was enhanced by combined treatment of
astrocytes with FGF2 and UTP (Figure 5A). By contrast,
2MeSADP was ineffective. Similar results were obtained
for cyclin D1. To extend these studies, we investigated the
effects of UTP and 2MeSADP on FGF2-induced astrocyte
mitogenesis. We found that FGF2-induced DNA synthesis
was also potentiated by UTP, but not by 2MeSADP
(Figure 5B). Thus, these studies were consistent with those
of cyclin A and D1 and suggested a role for P2Y2/4
receptors. To investigate further the type of P2 receptor
Figure 2. Extracellular ATP enhances cyclin A expression induced by
FGF2. (A) Quiescent, primary cultures of rat cortical astrocytes were
treated with ATP (100 mM), FGF2 (25 ng/ml) or a combination of ATP
and FGF2 for 20 h. Lysates were subjected to SDS-PAGE, and cyclin A
expression was measured by immunoblotting. Cyclin A was identiﬁed by
co-migration with a positive control (PC). Blots were also probed with
anti-actin antibodies as a loading control. ATP potentiated the ability of
FGF2 to stimulate expression of cyclin A. (B) Results (mean T SEM)
from four independent experiments in which astrocyte cultures were
treated as described in (A). FGF2-induced cyclin A expression was
signiﬁcantly enhanced by extracellular ATP (*P G 0.01).
Figure 3. ERK mediates the enhancement of cyclin D1 expression
induced by FGF2 and extracellular ATP. To determine whether the
potentiation of FGF2-induced cyclin D1 expression by extracellular ATP
was mediated by ERK, U0126 (10 mM, 30 min), an inhibitor of MEK, the
upstream activator of ERK, was added to quiescent, primary cultures of
rat cortical astrocytes prior to treatment with ATP (100 mM), FGF2
(25 ng/ml) or a combination of ATP and FGF2 for 20 h. (A) Lysates
were subjected to SDS-PAGE, and cyclin D1 expression was measured
by immunoblotting. (B) Results (mean T SEM) from three independent
experiments in which astrocyte cultures were treated as described in (A).
Blockade of the ERK cascade signiﬁcantly inhibited the expression of
cyclin D1 induced by FGF2 as well as the potentiation of FGF2-induced
cyclin D1 by extracellular ATP (*: FGF2 + ATP compared to FGF2, P G
0.05; FGF2 + U0126 compared to FGF2, P G 0.05; FGF2 + ATP + U0126
compared to FGF2 + ATP, P G 0.001).
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azophenyl-20,40disulphonic acid (PPADS), an antagonist of
UTP-stimulated, P2Y2 receptors in astrocytes [28, 29]. We
found that when astrocytes were treated with 50 mM
PPADS 15 min prior to addition of UTP, DNA synthesis
stimulated by UTP was reduced by 85% (n = 3). We
also investigated the effect of PPADS on the ability of UTP
to enhance FGF2-induced mitogenesis but found that
PPADS partially inhibited the mitogenic effect of FGF2
in the absence of UTP (data not shown), perhaps suggest-
ing that basal extracellular nucleotides contribute to FGF2
mitogenic activity, as reported for other cellular responses
[30]. Collectively, the effects of UTP on FGF2-induced
cyclin expression and mitogenesis, together with the
inhibitory effect of PPADS on UTP-stimulated DNA syn-
thesis, suggest a role for P2Y receptors, possibly P2Y2,i n
mediating the potentiating effects of extracellular nucleo-
tides on FGF2 responses in astrocytes.
P2X7 receptors have also been linked to cellular pro-
liferation in a subpopulation of lymphoid cells [31] and in
Jurkat cells [30], although activation of these ionotropic
P2X receptors can also lead to apoptosis in several cell
types, including lymphocytes [33] and microglia [34].
Because functional P2X7 receptors are expressed in as-
trocytes [35Y38], we examined the effect of stimulating
these receptors on FGF2-induced mitogenesis. We found
that activation of P2X7 receptors by 20,30-O-(4-benzoyl)-
benzoyl-ATP (BzATP; 100 mM) reduced FGF2-induced
mitogenesis by over 90% in primary cultures of rat cortical
astrocytes (Figure 6). The decrease in DNA synthesis was
not due to cytotoxicity as measured by trypan blue ex-
clusion. For example, the percentage of trypan blue pos-
itive cells in cultures untreated or treated with 100 mM
BzATP, 25 ng/ml FGF2 or the combination of BzATP
and FGF2 for 22 h did not exceed 6%, whereas in cul-
tures treated with staurosporine, approximately 75% of
the cells were trypan blue positive after 22 h (n = 3).
Similar results were obtained with a tetrazolium-based test
of cell viability (data not shown). Thus, the results pre-
sented here, together with those presented previously [20]
suggest that P2Y receptors and P2X receptors exert
opposing effects on FGF2-induced cellular proliferation
in astrocyte cultures.
ERK signaling mediates proliferation and differentiation
as well as growth arrest, depending on the duration and
intensity of ERK activation [39, 40]. Because both P2Y
and P2X7 receptors are linked to ERK in astrocytes and
Figure 4. Blockade of the ERK cascade inhibits cyclin A expression
induced by FGF2 and extracellular ATP. (A) U0126 (10 mM, 30 min) was
added to quiescent, primary cultures of rat cortical astrocytes prior to
treatment with ATP (100 mM), FGF2 (25 ng/ml) or a combination of ATP
and FGF2 for 20 h. Lysates were subjected to SDS-PAGE, and cyclin A
expression was measured by immunoblotting. (B) Results (mean T SEM)
from three independent experiments in which astrocyte cultures were
treated as described in (A). Blockade of the ERK cascade signiﬁcantly
inhibited the expression of cyclin A induced by FGF2 as well as the
potentiation of FGF2-induced cyclin A by extracellular ATP (*: FGF2 +
ATP compared to FGF2, P G 0.001; FGF2 + U0126 compared to FGF2,
P G 0.05; FGF2 + ATP + U0126 compared to FGF2 + ATP, P G 0.001).
Figure 5. P2Y purine/pyrimidines receptors mediate the synergistic
effects of extracellular ATP on FGF2-induced cyclin expression and
mitogenesis. (A) Quiescent, primary cultures of rat cortical astrocytes
were treated with ATP (100 mM) UTP (100 mM), 2MeSADP (10 mM),
FGF2 (25 ng/ml) or a combination of nucleotides and FGF2 for 20 h.
Lysates were subjected to SDS-PAGE, and cyclin A expression was
measured by immunoblotting. Blots were also probed with anti-actin
antibodies as a loading control. UTP and ATP, but not 2MeSADP,
potentiated the ability of FGF2 to stimulate expression of cyclin A.
Similar results were obtained in three independent experiments. (B)
Quiescent, primary cultures of rat cortical astrocytes were treated with
ATP (100 mM) UTP (100 mM), 2MeSADP (10 mM), FGF2 (25 ng/ml) or
a combination of nucleotides and FGF2, and DNA synthesis was measured
as described in Materials and methods.
3H-Thymidine incorporation in
control cultures was 15,714 T 3568 cpm/mg protein (mean T SEM; n = 6).
FGF2-induced DNA synthesis was signiﬁcantly enhanced by UTP (*P G
0.05).
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duration and intensity of ERK signaling stimulated by P2Y
and P2X7 receptors in astrocytes. Astrocytes were treated
with UTP (100 mM) or BzATP (100 mM) for 5, 30, 60, 120,
or 180 min, and stimulation of ERK1/2 was determined by
dual phosphorylation of threonine 202 and tyrosine 204
residues. We found that UTP stimulated strong ERK1/2
phosphorylation at 5 min which declined thereafter and
returned to baseline after 120 min; by contrast, BzATP
stimulation of ERK1/2 was less intense at 5 min but
remained elevated above baseline at 180 min (Figure 7).
Quantiﬁcation of data from this and an identical, indepen-
dent experiment revealed that UTP stimulated an approx-
imately 10-fold increase in ERK1/2 phosphorylation at
5 min as compared to about three-fold for BzATP, while at
3 h, no stimulation was observed with UTP but approxi-
mately three-fold stimulation was maintained by BzATP.
Thus, P2Y receptor activation led to an initially intense but
transient activation of ERK whereas activation of ERK by
P2X receptors in astrocytes was initially less intense but
more sustained. This ﬁnding is consistent with studies in
other cells in which growth arrest is mediated by a sus-
tained ERK signal whereas proliferation is linked to a
transient ERK activation [39, 40].
Discussion
The major ﬁndings presented here are (1) extracellular
ATP enhances the ability of FGF2 to induce the expression
of cyclin D1 and cyclin A, cell cycle regulatory proteins
involved in the entry and progression of mammalian cells
through the G1 and S phases of the cell cycle, (2) the
synergistic effects of extracellular ATP are mediated by
signaling from P2Y purine/pyrimidine receptors to ERK,
and (3) stimulation of P2X receptors inhibits the mitogenic
activity of FGF2. These results may have implications
regarding CNS development as well as reactive gliosis that
occurs after CNS injuries.
Extracellular ATP has both short-term and long-term
biological activities [43]. Of particular interest to nervous
system development as well as CNS injury and repair is its
ability to function as a trophic factor, either alone or as a
co-mitogen in conjunction with polypeptide growth factors
[14, 19]. For example, Heppel and colleagues described
synergistic interactions between extracellular ATP and
growth factors such as EGF and PDGF in ﬁbroblasts and
neuroblastoma cell lines [44, 45]. In astrocytes, we found
that extracellular ATP markedly potentiated FGF2-induced
mitogenesis [20]. However, little is known about the ef-
fects of extracellular ATP on cell cycle regulatory mech-
anisms, particularly in cells of the central nervous system.
In a ﬁbroblast cell line, extracellular ATP induced expres-
sion of cyclin A [46]. In mouse embryo and human fetus
ﬁbroblast cell lines in which placental alkaline phosphatase
exerts growth factor-like effects, extracellular ATP poten-
tiated the expression of cyclins A and E induced by pla-
cental alkaline phosphatase [47]. FGF2 is a mitogen for
many, but not all, cell types. For example, in medial
smooth muscle cells, FGF2 stimulated proliferation and
expression of cyclin A, but in intimal smooth muscle cells,
proliferation was only weakly stimulated by FGF2 and cy-
clin A expression was not induced [48]. Here we report for
the ﬁrst time that extracellular ATP enhances FGF2-in-
duced expression of cyclins involved in cell cycle entry
and progression through the G1 phase (cyclin D1) as well
entry and progression through the S phase (cyclin A) of the
cell cycle.
Our studies demonstrate that the increased expression of
cyclin D1 and cyclin A induced by FGF2 and extracellular
Figure 6. P2X receptors inhibit FGF2-induced mitogenesis in astrocytes.
Quiescent, primary cultures of rat cortical astrocytes were treated with
BzATP (100 mM), FGF2 (25 ng/ml) or a combination of BzATP and
FGF2, and DNA synthesis was measured as described in Materials and
methods. FGF2-induced DNA synthesis was signiﬁcantly inhibited by
BzATP (*P G 0.001; n = 6).
Figure 7. The duration and intensity of ERK phosphorylation differs between P2Y and P2X receptor signaling. Quiescent, primary cultures of rat
cortical astrocytes were treated with UTP (100 mM) or BzATP (100 mM) for the times indicated. ERK1/2 phosphorylation was measured as described in
Materials and methods. Stimulation of P2Y receptors with UTP elicited an intense but transient ERK phosphorylation whereas stimulation of P2X
receptors with BzATP evoked an initially less intense but more sustained ERK phosphorylation. Similar results were obtained in an independent
experiment.
334 J.T. Neary et al.ATP involves ERK because cyclin expression was atten-
uated by blocking MEK, the upstream activator of ERK.
These ﬁndings are consistent with those from studies in
ﬁbroblasts that demonstrate that up-regulation of cyclin D1
by PDGF was dependent on ERK activation [49]. Impor-
tantly, blockade of the ERK cascade also signiﬁcantly
inhibited the ability of extracellular ATP to enhance FGF2-
induced cyclin expression. These ﬁndings indicate that the
ERK cascade plays an important role in mediating the co-
mitogenic activity of extracellular ATP.
Our studies also indicate that P2Y purine/pyrimidine
receptors mediate the potentiating effects of extracellular
nucleotides on FGF2-induced cyclin expression and astro-
cyte mitogenesis, whereas P2X receptors, possibly the
P2X7 subtype, inhibit the mitogenic activity of FGF2 in
astrocytes. Previous studies demonstrated that rat cortical
astrocytes express both P2Y and P2X receptors [24, 36,
38]. For P2Y receptors, RT-PCR studies revealed that
primary cultures of cortical astrocytes prepared from one-
day-old rat pups contain P2Y1, P2Y2, P2Y4 receptors, but
not P2Y6 receptors [24]. A more recent report indicated
that P2Y6 receptors are expressed in astrocytes prepared
from seven-day-old rats [36]. Differences in subtype
expression may be due to differences in developmental
patterns of receptor expression or variations in culture
conditions. Here we found that UTP, but not 2MeSADP,
enhanced cyclin expression stimulated by FGF2. This
ﬁnding is consistent with the observation that UTP
enhanced the ability of FGF2 to stimulate DNA synthesis
whereas 2MeSADP was ineffective. In addition, PPADS,
an antagonist of UTP-stimulated, P2Y2 receptors in
astrocytes [28, 29], attenuated DNA synthesis stimulated
by UTP. Interestingly, PPADS also partially reduced FGF2
mitogenic activity in the absence of UTP. This may
suggest cross-talk between P2Y2/4 receptors and FGF2
receptors, but further studies beyond the scope of this work
are needed to investigate this possibility. Collectively, our
results suggest that P2Y2 and/or P2Y4 receptors mediate
the synergistic effects of extracellular nucleotides on
FGF2-induced cyclin expression.
P2X7 receptors are also expressed in cultured astrocytes
[35, 36, 38] and are coupled to ERK in these and other
cells [32, 35, 37]. Functionally, cellular proliferation was
observed upon expression of recombinant P2X7 receptors
in lymphoid cells lacking these receptors [31]. In addition,
increased proliferation was also noted in Jurkat cells after
stimulation of endogenous P2X7 receptors [32]. However,
activation of P2X7 receptors leads to apoptosis in several
cell types, including lymphocytes [33] and microglia [34].
Here we found that, in cultured astrocytes, the P2X7
receptor agonist BzATP inhibited the mitogenic activity
of FGF2. Cytotoxicity experiments indicated that this was
not due to a loss of cell viability. The opposing effects of
P2X and P2Y receptor stimulation on FGF2-induced
mitogenesis might be mediated at least in part by differ-
ences elicited in ERK responses. ERK can regulate cellular
proliferation, differentiation or growth arrest, depending on
the intensity and duration of the response and the cell type
[50]. For example, in some cell types a sustained ERK
signal is associated with growth arrest whereas a transient
signal leads to proliferation [39, 40]. Consistent with this,
here we found that stimulation of P2Y receptors elicited an
intense but transient ERK signal whereas that evoked by
P2X receptors was initially weaker but more sustained.
Further studies are needed to explore the effects of P2X
receptors on cell cycle regulation and whether their
inhibitory effects are due to the expression of cyclin-
dependent protein kinase inhibitors.
Because FGF2 and ATP are increased after CNS injury
and contribute to the gliotic response, the results presented
here may be relevant to the hyperplasia observed in adult
brains after trauma and stab wounds. The enhancement of
FGF2-induced cyclin expression by extracellular ATP
supports the suggestion of Nakatsuji and Miller [8] that
changes in the expression of cell cycle regulatory proteins
may be involved in the increase in astrocyte proliferation
observed after injury to the adult CNS. The reactive as-
trocytes formed in injured CNS regions impact the re-
establishment of neural connections and communication.
Since reactive astrocytes produce a variety of molecules
that can impede as well as promote axonal regeneration
[51, 52], advances in our understanding of the mechanisms
that mediate the formation of reactive astrocytes may offer
an opportunity to enhance the beneﬁcial, axonal growth-
promoting features of reactive astrocytes while attenuating
their harmful, growth-inhibiting properties. Thus, an
understanding of the mechanisms leading to reactive
astrocytes and the glial scar may provide new approaches
to restore losses in motor skills and cognitive functions
caused by CNS injury.
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